Description: Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Home Page: www.wanbury.com
BSEL Tech Park, B-Wing
Navi Mumbai,
400703
India
Phone:
91 22 6794 2222
Officers
| Name | Title |
|---|---|
| Mr. K. Chandran | Vice Chairman |
| Mr. Vinod R. Verma | Chief Financial Officer |
| Mr. Jitendra J. Gandhi | Compliance Officer & Company Sec. |
| Dr. Shireesh Ambhaikar | Pres of Operations - API Bus. |
| Mr. Nanasaheb Gunjal | Sr. VP of QA,QC & RA |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 1.5628 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.2581 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1437 |